Immunotherapy

Current Opinion in Otolaryngology and Head and Neck Surgery

Volumn 18, Issue 3, 2010, Pages 206-212

  Osguthorpe, John David ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Food sensitivity; Immunotherapy; Recombinant allergen; T helper 17 lymphocyte; T regulatory lymphocyte

Indexed keywords

RECOMBINANT ALLERGEN; ALLERGEN;

CLINICAL PRACTICE; CLINICAL RESEARCH; COMPARATIVE STUDY; EVIDENCE BASED MEDICINE; FOOD ALLERGY; HOUSE DUST ALLERGY; HUMAN; IMMUNOTHERAPY; MEDICAL LITERATURE; POLLEN ALLERGY; PRIORITY JOURNAL; PUBLICATION; REGULATORY T LYMPHOCYTE; RESPIRATORY TRACT ALLERGY; REVIEW; STANDARDIZATION; SUBCUTANEOUS TISSUE; SUBLINGUAL GLAND; TH17 CELL; DESENSITIZATION; PROCEDURES; RHINITIS, ALLERGIC, PERENNIAL; RHINITIS, ALLERGIC, SEASONAL; SUBCUTANEOUS DRUG ADMINISTRATION;

ALLERGENS; DESENSITIZATION, IMMUNOLOGIC; HUMANS; IMMUNOTHERAPY; INJECTIONS, SUBCUTANEOUS; RHINITIS, ALLERGIC, PERENNIAL; RHINITIS, ALLERGIC, SEASONAL;

EID: 77952412750     PISSN: 10689508     EISSN: None     Source Type: Journal    
DOI: 10.1097/MOO.0b013e3283385881     Document Type: Review

References (40)

1. Wallace D, Dykewicz M, Bernstein D, et al. The diagnosis and management of rhinitis: an updated practice parameter. J Allergy Clin Immunol 2008;122: S1-S84. (Pubitemid 352033573)
2. Passalacqua G, Durham S. Allergic rhinitis and its impact on asthma update: • allergen immunotherapy. J Allergy Clin Immunol 2007;119:881-891. This is the first update after the initial groundbreaking offering on 'Allergic rhinitis and its impact on asthma' in 2001. Though there are brief synopses of current knowledge on in-vitro aspects of immunotherapy, the thrust of the article is the clinical efficacy and safety of SCIT and SLIT, and the applications of such within both developed and medically underserved venues. (Pubitemid 46527840)
3. Calderon M, Alves B, Jacobson M, et al. Allergen injection immunotherapy for seasonal allergic rhinitis. Cochrane Database Syst Rev 2007;1: CD001936.
4. James L, Durham S. Update on mechanisms of allergen injection immunotherapy. Clin Exp Allergy 2008;38:1074-1089.
5. Bosquet P, BrozekJ, Bachert C, et al. The CONSORT statement checklist in allergen-specific immunotherapy: a GA2LEN paper. Allergy 2009;64:1737-1745.
6. Akdis CA, Akdis M. Mechanisms and treatment of allergic disease in the big •• picture of regulatory T cells. J Allergy Clin Immunol 2009;123:735-746. The article is a reasonably easy to read and very current presentation that commences with a summary of T-helper 2 cells' contribution to allergy, and then details T-reg cells and the changes that occur in such during immunotherapy.
7. Ozdemir C, Akdis M, Akdis CA. T regulatory cells and their counterparts: masters of immune regulation. Clin Exp Allergy 2009;39:626-639.
8. Yamazaki S, Steinman R. Dendritic cells as controllers of antigen-specific Foxp3+ regulatory T cells. J Dermatol Sci 2009;54:69-75.
9. Zhao C, Li T, He S, et al. Specific immunotherapy suppresses Th2 responses via modulating TIM1/TIM4 interaction on dendritic cells. Allergy 2009. [Epub ahead of print]
10. Leech M, Anderton S. Antigen-based therapies targeting the expansion of regulatory T cells in autoimmune and allergic disease. Chem Immunol Allergy 2008;94:201-210.
11. Sleiman P, Flory J, Imielinski M, et al. Variants of DENND1B associated with • asthma in children. N Engl J Med 2009;362:36-44. Through a genomewide association study of a large group of patients with asthma, and matched controls, various potential loci for atopy were identified. One significantly associated with asthma is expressed on both APC and aT-reg cells, and modulates the T-helper 1/T-helper 2 cytokine cascade and other inflammatory signaling pathways.
12. Radulovic S, Jacobson M, Durham M, et al. Grass pollen immunotherapy induces Foxp3-expressing CD4+CD25+ cells in the nasal mucosa. J Allergy Clin Immunol 2008;121:1467-1472.
13. Ciprandi G, DeAmici M, Negrini S, et al. TGF-b and IL-17 serum levels and specific immunotherapy. Int Immunopharmcol 2009;9:1247-1249.
14. Miossec P, Korn T, Kuchroo V. Interleukin-17 and type 17 helper T-cells. • N Engl J Med 2009;361:888-898. This is a succinct and well illustrated summary of current knowledge on T-helper 17 cells, and their relationship to T-reg.
15. Oboki K, Ohno T, Saito H. Th17 and allergy. Allergol Int 2008;57:121-134.
16. Wilson R, Whitehead G, Nakano H, et al. Allergic sensitization through the airway primes Th17-dependent neutrophilia and airway hyperresponsiveness. Am J Respir Crit Care Med 2009;180:720-730.
17. Goriely S, Cavoy R, Goldman M. Interleukin-12 family members and type I interferons in Th17-mediated inflammatory disorders. Allergy 2009;64:702-709.
18. Wakashin H, Hirose K, Maezawa Y, et al. IL-23 and Th17 cells enhance Th2-cell-mediated eosinophilic airway inflammation in mice. Am J Respir Crit Care Med 2008;178:1023-1032.
19. Ciprandi G, DeAmici M, Murdaca G, et al. Serum interleukin-17 levels are related to clinical severity in allergic rhinitis. Allergy 2009;64:1375-1378.
20. Nieminen K, Valovirta E, Savolainen J. Clinical outcome and IL-17, IL-23, IL-27 • and FOXP3 expression in peripheral blood mononuclear cells of pollenallergic children during sublingual immunotherapy. Pediatr Allergy Immunol 2009. [Epub ahead of print] Article presents a synopsis of current knowledge of aT-reg induced changes during immunotherapy, and then a dose ranging study of sublingual therapy for pollens, tracking the changes in T-reg and T-helper 17 cells and their cytokines.
21. Nelson H. Preparing and mixing allergen vaccines for subcutaneous immunotherapy. Clin Allergy Immunol 2008;21:303-320.
22. Slater J. Standardized allergen vaccines in the United States. J Clin Allergy Immunol 2008;21:273-281.
23. Van Ree M, Chapman M, Ferreira F, et al. The CREATE project. Allergy 2008;63:310-326.
24. Reuter A, Luttkopf D, Vieths S. New frontiers in allergen standardization. Clin Exp Allergy 2009;39:307-309.
25. Larenas-Linnemann D. Certainties and doubts about sublingual and oral •• immunotherapy in children. Curr Opin Allergy Clin Immunol 2009;9:558-567. The literature on immunotherapy in children published between July 2007 and July 2009 is summarized, and articles graded on quality of evidence. Though some of such involves SCIT and food immunotherapy, the most detailed commentary involves uncertainties surrounding SLIT, from dose and administration schedule to efficacy in asthma.
26. Scurlock A, Burks W, Jones S. Oral immunotherapy for food allergy. Curr Allergy Asthma Rep 2009;9:186-193.
27. Lack G. Food Allergy. N Engl J Med 2008;359:1252-2160.
28. Vickery B, Burks A. Immunotherapy in the treatment of food allergy: focus on oral tolerance. Curr Opin Allergy Clin Immunol 2009;9:1-7.
29. Du Toit G, Santos A, Roberts G, et al. The diagnosis of IgE-mediated food • allergy in childhood. Pediatr Allergy Immunol 2009;20:309-319. This is a straightforward presentation of the incidence, diagnosis and currently under investigation immunotherapy approaches to food sensitivities.
30. Tey D, Heine R. Egg allergy in childhood. Curr Opin Allergy Clin Immunol. 2009;9:244-250. This is an update on the diagnosis and treatment of egg allergy, and serves as a good review for the more common clinical approaches to nonlife-threatening food sensitivities.
31. Jones S, Pons L, Roberts J, et al. Clinical efficacy and immune regulation with peanut oral immunotherapy. J Allergy Clin Immunol 2009;124:292-300.
32. Calderon M, Penagos M, Durham S. Sublingual immunotherapy for allergic rhinoconjunctivitis, allergic asthma, and prevention of allergic diseases. Clin Allergy Immunol 2008;21:359-375.
33. Nieto A, Mazon A, Pamies R, et al. Sublingual immunotherapy for allergic • respiratory diseases: an evaluation of meta-analyses. J Allergy Clin Immunol 2009;124:157-161. Written in a very straightforward manner, this is a GA2LEN approach that deconstructs a number of meta-analyses of the literature on the efficacy of SLIT as an alternative to SCIT.
34. Toskala E. A contemporary review of sublingual immunotherapy. Laryngoscope 2009;119:2178-2181.
35. Calderon M, Mosges R, Hellmich M, Demoly P. Towards evidence-based medicine in specific grass pollen immunotherapy. Allergy 2009. [Epub ahead of print]
36. Marogna M, Spadolini I, Massolo A, et al. Long-term comparison of sublingual immunotherapy vs inhaled budesonide in patients with mild persistent asthma due to grass pollen. Ann Allergy Asthma Immunol 2009;102:69-75.
37. Ott H, Sieber J, Brehler R, et al. Efficacy of grass pollen sublingual immunotherapy for three consecutive seasons and after cessation of treatment: the ECRIT study. Allergy 2009;64:1394-1401.
38. Compalati E, Passalacqua G, Bonini M, Canonica G. The efficacy of sublingual immunotherapy for house dust mites respiratory allergy: results of a GA2LEN meta-analysis. Allergy 2009;64:1570-1579.
39. O'Hehir R, Gardner L, de Leon M, et al. House dust mite sublingual • immunotherapy. Am J Respir Crit Care Med 2009;180:936-947. This is a well detailed, both in-vitro and in-vivo, study of SLIT for HDM sensitivity, arguably providing the first unassailable validation of such.
40. Senti G, Johansen P, Kundig T. Intralymphatic immunotherapy. Curr Opin Allergy Clin Immunol 2009;9:537-543.